MLYS
Mineralys Therapeutics Inc.
$43.36
+$1.20(+2.83%)
67
Overall
60
Value
100
Tech
42
Quality
Market Cap
$2.50B
Volume
1.30M
52W Range
$8.24 - $42.71
Target Price
$43.75
EPS Estimates Overview
| Current Quarter | $-0.71 | Next Quarter | $-0.74 |
| Current Year | $-2.95 | Next Year | $-3.06 |
| QoQ Growth | -4.2% | YoY Growth | -3.7% |
| 3Y EPS CAGR | N/A | Target Price | $43.75 |
| Consensus | Buy | Upside | +0.9% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLYS | $43.36 | +2.8% | 1.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mineralys Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW